EUVIMEDEUVIMED entdecken
Crossref

Integrated “gut–liver”-on-a-chip (iGLoC): an immune-competent and metabolically active microphysiological model of the gut–liver axis for drug screening, validated by abemaciclib pharmacokinetics, hepatotoxicity, and drug–drug interaction studies

Sultan K AlShmmari, Dana Cialla-May, Jürgen Popp, Mohammed Zourob, Qasem Ramadan

Lab on a Chip · 2026

DOI: 10.1039/d6lc00377j ↗

Kurz gefasst

Fachartikel in der Zeitschrift Lab on a Chip, 2026. Verfasst von Sultan K AlShmmari und 4 weiteren Autor:innen. Beteiligte Einrichtung: Leibniz Institute of Photonic Technology, Member of Leibniz Health Technologies, Member of the Leibniz Centre for Photonics in Infection Research (LP…. Hauptthemen laut MEDLINE: Benzimidazoles, Liver, Aminopyridines, Lab-On-A-Chip Devices. Die Arbeit nennt 53 Literaturangaben. Gefördert von: Alfaisal University.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

iGLoC: immune-competent in vitro model recapitulates gut–liver PK of abemaciclib, generating clinically relevant metabolites, DDIs, and hepatotoxicity signatures for preclinical screening of small-molecule cancer therapeutics.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

BenzimidazolesLiverAminopyridinesLab-On-A-Chip DevicesHumansMicrophysiological SystemsCaco-2 CellsDrug InteractionsDrug Evaluation, PreclinicalHep G2 CellsAnimals

Substanzen

BenzimidazolesabemaciclibAminopyridines

Autor:innen und Institutionen

  • Leibniz Institute of Photonic Technology, Member of Leibniz Health Technologies, Member of the Leibniz Centre for Photonics in Infection Research (LPI), Albert-Einstein-Straße 9, 07745 Jena, Germany.
  • College of Science & General Studies, Alfaisal University, Riyadh 11533, Saudi Arabia. qalramadan@alfaisal.edu.
  • Institute of Physical Chemistry (IPC) and Abbe Center of Photonics (ACP), Friedrich Schiller University Jena, Member of the Leibniz Centre for Photonics in Infection Research (LPI), Helmholtzweg 4, 07743 Jena, Germany.

Förderung

  • Alfaisal University

Zitieren

APA

AlShmmari, S. K., Cialla-May, D., Popp, J., Zourob, M., & Ramadan, Q. (2026). Integrated “gut–liver”-on-a-chip (iGLoC): an immune-competent and metabolically active microphysiological model of the gut–liver axis for drug screening, validated by abemaciclib pharmacokinetics, hepatotoxicity, and drug–drug interaction studies. Lab on a Chip. https://doi.org/10.1039/d6lc00377j

Vancouver

AlShmmari SK, Cialla-May D, Popp J, Zourob M, Ramadan Q. Integrated “gut–liver”-on-a-chip (iGLoC): an immune-competent and metabolically active microphysiological model of the gut–liver axis for drug screening, validated by abemaciclib pharmacokinetics, hepatotoxicity, and drug–drug interaction studies. Lab on a Chip. 2026. doi:10.1039/d6lc00377j

BibTeX
@article{AlShmmari2026,
  author = {AlShmmari, Sultan K and Cialla-May, Dana and Popp, Jürgen and Zourob, Mohammed and Ramadan, Qasem},
  title = {Integrated “gut–liver”-on-a-chip (iGLoC): an immune-competent and metabolically active microphysiological model of the gut–liver axis for drug screening, validated by abemaciclib pharmacokinetics, hepatotoxicity, and drug–drug interaction studies},
  journal = {Lab on a Chip},
  year = {2026},
  doi = {10.1039/d6lc00377j}
}
Kostenlos starten →